Real-World Management of Macular Edema Secondary to Retinal Vein Occlusion with Intravitreal Aflibercept: 24-month Results from the AURIGA Observational Study
Journal
Ophthalmology and therapy
Journal Volume
13
Journal Issue
1
Date Issued
2024-01
Author(s)
Giocanti-Aurégan, Audrey
Donati, Simone
Hoerauf, Hans
Allmeier, Helmut
Rittenhouse, Kay D
Machewitz, Tobias
Abstract
AURIGA is the largest real-world study to date to evaluate intravitreal aflibercept (IVT-AFL) treatment of diabetic macular edema or macular edema secondary to retinal vein occlusion (RVO) in routine clinical practice. Here, we report the 24-month outcomes in the RVO cohort from France, Germany, Italy, and Taiwan.
Subjects
Anti-vascular endothelial growth factor; Branch retinal vein occlusion; Central retinal vein occlusion; Intravitreal aflibercept; Macular edema; Observational study; Optical coherence tomography; Real-world evidence; Retinal disease; Retinal vein occlusion
Type
journal article